Buprenorphine And Naloxone Film
Product Images NDC 3215-6522

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Buprenorphine And Naloxone (NDC 3215-6522). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aveva Drug Delivery Systems Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure3.jpg (Figue3)

An anatomical illustration showing a frontal view of an open mouth, focusing on the placement area for a buccal or sublingual film. The depiction includes the upper and lower teeth, tongue, and inner mouth cavity, typically used to demonstrate where to position the film for absorption.*

FDA Label Image

Figure1.jpg (Figure1)

An instructional illustration showing hands holding a film strip, demonstrating how to handle or prepare the buprenorphine and naloxone buccal/sublingual film before administration.*

FDA Label Image

Figure2.jpg (Figure2)

Instructional illustration showing hands opening a sealed pouch by tearing at a notch and removing a film strip, followed by peeling off the backing from the film product to prepare it for buccal or sublingual administration.*

FDA Label Image

Figure4.jpg (Figure4)

Instructional illustration showing the placement of a buprenorphine and naloxone sublingual or buccal film inside the mouth. The image demonstrates holding the film with fingers and positioning it under the tongue or against the inner cheek for administration.*

FDA Label Image

Ctn2mg (Image01)

Packaging label for Buprenorphine and Naloxone Sublingual Film, 2 mg/0.5 mg strength. The label indicates the film is for buccal and sublingual administration, with 30 pouches each containing one film. The label includes usage warnings, storage instructions, and is manufactured by Aveva Drug Delivery Systems Inc. The NDC is 3215-6521-30.*

FDA Label Image

Ctn4mg (Image02)

Packaging label for Buprenorphine and Naloxone Sublingual Film 4 mg/1 mg by Aveva Drug Delivery Systems Inc. The label notes 30 pouches each containing 1 sublingual film. It includes usage instructions, storage conditions, warnings, and the manufacturer details. The barcode and NDC 3215-6522-30 are visible.*

FDA Label Image

Ctn8mg.jpg (Image03)

Packaging label for Buprenorphine and Naloxone Sublingual Film, 8 mg/2 mg strength. The label indicates 30 pouches, each containing one sublingual film. It is marked for prescription use only and manufactured by Aveva Drug Delivery Systems Inc. The label includes usage warnings, storage instructions, and directions for buccal or sublingual administration.*

FDA Label Image

Ctn12mg.jpg (Image04)

Packaging label for Buprenorphine and Naloxone Sublingual Film 12 mg/3 mg by Aveva Drug Delivery Systems Inc. The label design is for a carton containing 30 individually packaged sublingual films. It includes dosage instructions, storage conditions, warnings about accidental ingestion by children, and directions for buccal and sublingual administration. A barcode and NDC number 32156-5243-0 are visible.*

FDA Label Image

Structurebuprenorpine.jpg (Structurebuprenorpine)

Chemical structure of buprenorphine, the active ingredient in the Buprenorphine and Naloxone film product by Aveva Drug Delivery Systems Inc., shown with its molecular features and a hydrochloride (HCl) salt form.*

FDA Label Image

Structurenaloxone.jpg (Structurenaloxone)

Chemical structure of buprenorphine, the active ingredient in Buprenorphine and Naloxone film. The diagram shows the molecular structure including rings and functional groups with a note indicating the presence of hydrochloride and two water molecules (HCl • 2H2O).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.